Venous thromboembolic pharmacological prophylaxis in severe traumatic acute subdural hematomas: Early prophylaxis is effective and safe.


Journal

American journal of surgery
ISSN: 1879-1883
Titre abrégé: Am J Surg
Pays: United States
ID NLM: 0370473

Informations de publication

Date de publication:
05 2022
Historique:
received: 31 03 2021
revised: 26 07 2021
accepted: 27 07 2021
pubmed: 9 8 2021
medline: 25 5 2022
entrez: 8 8 2021
Statut: ppublish

Résumé

The purpose of this study was to evaluate the optimal timing and type of pharmacological venous thromboembolism prophylaxis (VTEp) in patients with severe blunt head trauma with acute subdural hematomas (ASDH). Matched cohort study using ACS-TQIP database (2013-2016) including patients with isolated ASDH. Outcomes of matched patients receiving early prophylaxis (EP, ≤48 h) and late prophylaxis (LP, >48 h) were compared with univariable and multivariable regression analysis. In 1,660 matched cases VTE complications (3.1% vs 0.5%, p < 0.001) were more common in the LP compared to the EP group. Multivariable regression analysis identified EP as an independent protective factor for VTE complications (OR 0.169, p < 0.001) but not mortality (p = 0.260). The adjusted risk for delayed craniectomy was not associated with EP compared to LP (p = 0.095). LMWH was independently associated with a lower mortality (OR 0.480, p = 0.008) compared to UH. Early VTEp (≤48 h) does not increase the risk for craniectomies and is independently associated with fewer VTE complications in patients with isolated ASDH. LMWH was independently associated with a lower mortality compared to UH.

Sections du résumé

BACKGROUND
The purpose of this study was to evaluate the optimal timing and type of pharmacological venous thromboembolism prophylaxis (VTEp) in patients with severe blunt head trauma with acute subdural hematomas (ASDH).
METHODS
Matched cohort study using ACS-TQIP database (2013-2016) including patients with isolated ASDH. Outcomes of matched patients receiving early prophylaxis (EP, ≤48 h) and late prophylaxis (LP, >48 h) were compared with univariable and multivariable regression analysis.
RESULTS
In 1,660 matched cases VTE complications (3.1% vs 0.5%, p < 0.001) were more common in the LP compared to the EP group. Multivariable regression analysis identified EP as an independent protective factor for VTE complications (OR 0.169, p < 0.001) but not mortality (p = 0.260). The adjusted risk for delayed craniectomy was not associated with EP compared to LP (p = 0.095). LMWH was independently associated with a lower mortality (OR 0.480, p = 0.008) compared to UH.
CONCLUSIONS
Early VTEp (≤48 h) does not increase the risk for craniectomies and is independently associated with fewer VTE complications in patients with isolated ASDH. LMWH was independently associated with a lower mortality compared to UH.

Identifiants

pubmed: 34364655
pii: S0002-9610(21)00454-2
doi: 10.1016/j.amjsurg.2021.07.048
pii:
doi:

Substances chimiques

Anticoagulants 0
Heparin, Low-Molecular-Weight 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1004-1009

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Auteurs

Dominik A Jakob (DA)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: Dominik.a.jakob@gmail.com.

Elizabeth R Benjamin (ER)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: Ebenja2@emory.edu.

Gustavo Recinos (G)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: Grecinos10@hotmail.com.

Camilla Cremonini (C)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: C.cremonini89@gmail.com.

Meghan Lewis (M)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: Meghan.Lewis@med.usc.edu.

Demetrios Demetriades (D)

Division of Trauma and Critical Care, University of Southern California, Los Angeles, CA, USA. Electronic address: Demetrios.Demetriades@med.usc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH